Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Research and development expenses, net	$ 50,177	$ 38,873
Commercial expenses	20,013	8,894
General and administrative expenses	16,977	13,158
Total operating loss	87,167	60,925
Financial expenses, net	2,626	648
Loss	$ 89,793	$ 61,573
Net loss per share attributable to ordinary shareholders, basic and diluted (in Dollars per share)	$ 1.52	$ 1.41
Weighted average number of shares used in computing net loss per share attributable to ordinary shareholders, basic and diluted (in Shares)	59,246,803	43,725,584